An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondy ...
Review of Safety and Efficacy With Adalimumab in Patients With Active Ankylosing Spondylitis - An Open-Label Study to Evaluate the Response to Adalimumab in Patients Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) Review of Safety and Efficacy With Adalimumab in Patients With Active Ankylosing Spondylitis - An Op ...